PF treatment decreases the levels of IL-1β(A) and TNFα(B) in plasma. by Ruo-Bing Guo (298949)

Decrease of mitochondrial membrane potential by silvestrol. by Takayuki Kogure (235048)

Figure 2. Decrease in contrast with age. by Aurélie Porcheron (385827)

CaA decreases the CSCs-like properties of malignant HaCaT cells by p38. by Ye Yang (297214)

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

Decreased miR-29b/c in GC tissue samples. by He Cui (229445)

Osteoporotic fracture healing was delayed and biomechanical property decreased in OVX rats. by Lin Chen (54305)

Aβ42 increases the level of tau in the cytosol and decreases the level of microtubule-bound tau. by Kanae Ando (1951501)

Ephrin-A2 and –A6 expression and EphA4 Tyr-602 phosphorylation decrease from nasal to temporal RGCs. by Ana Laura Ortalli (159899)

DG treatment decreased the oxidative stress induced by Aβ_1–42. by Xiaolei Zhu (325492)

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Exogenous IL-2 and IL-7 decrease suppression of Teff proliferation and cytokine production, but do not decrease apoptosis. by Yvonne Vercoulen (259275)

Mfsd2a KO mice have decreased liver TG with normal liver metabolism. by Justin H. Berger (297156)

Reduced I_A decreases the stimulus threshold for short-term synaptic plasticity. by Ángela Fontán-Lozano (193161)

<i>Dmd^mdx</i> rats are characterized by muscle weakness and by a decrease in a spontaneous activity. by Thibaut Larcher (331981)

“…<i>Dmd^mdx</i> rats showed fatigue with a decreased force grip across the five pulls, and significant values are obtained for the two last trials that were reduced to ∼70% when compared to Trial 1. …”

Forest plot of reported treatment effect* of pregabalin by 5-year interval and overall. by Emma T. L. Cheng (14486376)

METH decreased basal pERK1/2 levels and potentiated ERK1/2 phosphorylation induced by 6-OHDA. by Amina El Ayadi (341955)

“…METH decreased activation of ERK 1/2 in a concentration-dependent manner (0, 0.5, and 1 mM at the 24 hr time point) and enhanced the activation of ERK1/2 after 6-OHDA exposure. …”

Reduced follicles, decreased ovulation and decreased fertilization of female Meox-2-cre/Separase S1121A mutant mice. by Juan Xu (225010)

HDACi exposure in DHA-treated cells enhanced decreases of Mcl-1 and p-ERK. A. by Chris Zhiyi Zhang (111721)

Tyrosine mutation of A30P decreases toxicity in <i>Δyhb1</i>. by Alexandra Kleinknecht (3164265)